Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia

The response of Philadelphia chromosome (Ph(+)) acute lymphoblastic leukemia (ALL) to treatment by BCR-ABL tyrosine kinase inhibitors (TKIs) has been disappointing, often resulting in short remissions typified by rapid outgrowth of drug-resistant clones. Therefore, new treatments are needed to impro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Koss, Brian, Morrison, Jeffrey, Perciavalle, Rhonda M., Singh, Harpreet, Rehg, Jerold E., Williams, Richard T., Opferman, Joseph T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2013
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3757371/
https://ncbi.nlm.nih.gov/pubmed/23881917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-06-440230
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak